Helix

Integrates genomics into healthcare solutions

San Mateo, California, United States

About Helix

Helix focuses on integrating genomics into healthcare to enhance patient care and drive growth for health organizations. They provide solutions that make genomic data accessible and actionable, allowing clients like health systems and life science companies to offer personalized healthcare at scale. Their services improve patient outcomes and reduce costs, creating strategic value for their clients. Helix also contributes to medical research by providing insights that accelerate the development of therapies and improve diagnosis and treatment. They operate a large clinical Next-Generation Sequencing (NGS) lab, which enables efficient genetic analysis and supports public health efforts in disease monitoring and outbreak response. Helix's goal is to transform healthcare through the power of genomics.

San Mateo, CaliforniaHeadquarters
2015Year Founded
$399.8MTotal Funding
SERIES_CCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Parental Leave
401(k) Company Match
401(k) Retirement Plan
Unlimited Paid Time Off
Remote Work Options
Home Office Stipend

Risks

Data privacy concerns may arise from expanding clinico-genomic datasets.
Rapid database expansion could face data management and quality control challenges.
AI model adoption may face skepticism from healthcare providers.

Differentiation

Helix operates one of the largest CLIA/CAP next-generation sequencing labs globally.
Their proprietary Exome+™ assay supports comprehensive population genomics initiatives.
Helix's clinico-genomic datasets integrate real-time updates and longitudinal data.

Upsides

Partnership with Komodo Health enhances Helix's clinico-genomic datasets for precision medicine.
AI-powered models predict drug responses, improving personalized treatment plans.
Growing demand for personalized medicine boosts Helix's market potential.